Nearly two years after the advent of vaccines against Covid-19, the pandemic is still, frustratingly, with us. The vaccines have done an excellent job at their primary mission, preventing severe disease or death. But they haven’t been as effective at keeping people from catching and spreading the virus — partly because SARS-CoV-2 has become more […]

In a fast-paced field like the biopharma industry, it’s vital to one’s mental and physical health to learn how to manage stress. This is especially true for C-suite executives. Some executives might book a massage or practice meditation to deal with their stress. Others, like Jessica Fees, CFO of Surface Oncology, and Karen Zaderej, CEO of Axogen, have […]

Initially, anti-PD-1/anti-PD-L1 therapies offered the hope of curing cancer. Experience showed that despite truly amazing results in some patients and the approval of five such therapeutics in the United States and Europe, they elicited a response in less than one-third of those receiving them. PD-L1 expression, while still an important biomarker, is not the static, “yes/no” predictor […]